Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible…
Published in the Journal of Clinical Oncology, results showed no difference in any outcomes, including overall survival, at two years…
Diagnostic Company's iSED Analyzers Deliver Seven-Fold Stability Increase to Improve Accuracy, Efficiency, and Patient Care SMITHFIELD, R.I., Sept. 16, 2025…
September 06, 2025 14:30 ET | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…
RIYADH, Saudi Arabia, Aug. 24, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient…
PrecivityAD2™ blood test now available in over seven additional countries with primary focus on regions with inadequate PET infrastructureST. LOUIS--(BUSINESS…
Fourth annual initiative supports World Diabetes Day 2025 with patient-led creativity and storytellingBASEL, Switzerland--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes…
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology.The minimally…